Autoimmune Diseases Flashcards

1
Q

AI disease

A
  • affect 5% of pop-incidence increased in women and developed countries
  • self antigen is recognized as foreign by immune system and there is a failure of regulation
  • effector mechanisms include types II, III, IV
  • may be organ specific, affecting only a few cells or systemic, multiple organs
  • no known cause or cure and treatment is aimed at controlling symptoms
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

factors contributing to development of AI diseases

A
  • immune factors-breakdown of T and B cell tolerance and the production of autoantibody/ IF autoreactive T cells
  • genetic factors
  • environmental factors
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

development of AI

A
  • trigger infection seems to be required- bacterial products required to induce autoimmune responses to injected self proteins
  • also increase in disease incidence with industrialization supports role for environmental factors
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

breakdown in B cell tolerance

A
  • central B cell tolerance-clonal deletion of self reactive cells in marrow-not all deleted
  • peripheral B cell tolerance-without T cell help, antigen activated B cells in the T cell zone die by apoptosis
  • B cells may also become anergic after encounter with soluble (self) antigen, then will be eliminated by T cell via Fas

**this all doesn’t happen in AI-or at least some of it

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

Breakdown in central T cell tolerance

A
  • normally T cells that bind to self peptides presented by MHC on thymic cells are deleted
  • defects in AIRE lead to the production of a variety of autoimmune B and T cell responses, and AI polyglandular disease

-even if negative selection works properly, some autoreactive cells do escape, theyre controlled by peripheral tolerance

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

breakdown in peripheral T cell tolerance

A
  • insufficient control of T cell costimulation
  • need 2 signals, self signal usually no co stim and anergy develops
  • autoreactive t cells may have low threshold for activation
  • allelic variants of CTLA4 can cause AI
  • CD40 of CD40L variants can mess up activation
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

breakdown in peripheral 2

A
  • lack of Tregs
  • Tregs have CD4, CD25, CTLA4, produce IL4, IL 1- and TGFb
  • require cell contact and CTLA4 to work
  • defects in Foxp3 can cause AI mainly in boys
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

TH17

A
  • helper CD4 cells secrete
  • activates fibroblasts, epithelial cells, keratinocytes, leads to secretion of cytokines and recruitment of IF cells
  • may accumulate in affected tissues in crohns disease, RA, psoriasis, allergic asthma
  • link between infection and AI?
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q

HLA

A
  • dominant genetic factor affecting susceptibility to AI
  • RR >150 down to 2 depending on HLA variations
  • B27 big one
  • also variants in AIRE, Fas, FasL, bcl2 (resistant to apoptosis) TNF, FoxP3, signalling molecules
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q

release of sequestered antigens

A
  • trauma to sites of immune privilege, normally entry of naive lymphocytes prevented but self antigens exposed by wound or infection and effector cells can get in
  • injury to eye releases eye antigens to blood, go to lymph nodes and activate T cells, effector cells come back and hurt other eye
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q

self protein modification

A
  • gluten degraded to resistant fragment
  • then deaminated
  • then cd4 cell responds to peptide presented by HLA DQ
  • IF effector cells cause villous atrophy
  • leads to diarrhea and malabsorption
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q

lyme disease

A

-HLA DR2,4 can lead to chronic arthritis

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q

molecular mimicry

A
  • self peptide looks enough like antigen than immune system gets confused and attacks
  • T cell activated by actual antigen then thinks our protein is antigen
  • also infection of APC, IF tissue damage/bystander, superantigens/LPS,
  • neoantigens (penicillin)
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
14
Q

infection and antigen presentation

A
  • thyroid cells don’t normally have HLA II (some of them)
  • IFN gamma produced during infection or nonspecific IF induced HLA class II
  • activated T cells recognize this and cause AI disease
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
15
Q

hashimoto’s disease

A

-thyroid gland resembles secondary lymphoid tissue with T and B cells present

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
16
Q

additional factors that can contribute to disease mechanism

A
  • chemicals
  • metals
  • hormones-estrogen- 90% in women
  • sunlight
  • stress
  • diet
  • age
17
Q

antibody mediated AI

A

single type of organ targeted by autoantibodies

  • organ specific
  • type II hypersensitivity
18
Q

hemolytic anemia

A
  • loss of RBCs after fixation of complement by IgG and IgM on RBCs
  • lysis or clearance via binding to Fc and complement receptors on phagocytes in the spleen and liver
19
Q

thrombocytopenia

A

-platelet antigens are the target of autoantibodies

20
Q

goodpastures syndome

A

antibody mediated

  • IgG against type IV collagen
  • IF in renal tissue
21
Q

grave’s disease

A

antibody mediated

-antibodies binds to TSH receptor and act as agonists so thyroid hormones overproduced

22
Q

myasthenia gravis

A

antibody mediated

  • antibodies to Ach receptors on muscles induce their endocytosis
  • antibodies also compete with Ach for binding with the receptors that are there, progressive muscle weakening
  • cholera toxin stabilizes receptors that are there
23
Q

insulin resistant diabetes

A

antibody mediated
-insulin binding to receptor is blocked by antibody so that insulin accumulates, hyperglycemia, resistance to insulin
NOT TYPE 1
-in some patients agonist antibodies for insulin deplete glucose resulting in hypoglycemia

24
Q

IgG passed through placenta

A
  • mom can pass IgG for TSH receptor to baby

- baby makes too much thyroid hormone, but can be corrected

25
Q

immune complex mediated AI disease

A
  • AI response is directed at multiple cells of the body, systemic
  • Type III response
26
Q

SLE

A

immune complex regulated

  • chronic systemic AI disease, flares and remissions
  • immune complexes have anti DNA, anti nucleosome
  • anti dsDNA diagnostic
  • specificity of response broadens over time
  • incidence is 1/200 with more women, african and asian
  • butterfly shaped rash, fatigue, headaches
27
Q

T cell mediated AI

A

antigens in tissue are targeted by TH1 cells

-type IV reaction

28
Q

insulin dependent DM

A

T cell mediated
-CD8 cells cytotoxic to pancreatic beta cells so that insulin production is low
1/800
-thirst and urination, weight loss, nausea, fatigue

29
Q

RA

A

T cell mediated

  • 1/1– 22-55
  • caused by production of antibodies that react with constant regions of other antibodies (rheumatoid factor) and infiltration of the joint synovium by IF cd4 and 8 cells
  • classified variably as immune complex mediated or t cell mediated
  • secretion of TNF a, IL1, IL6,7 leads to recruitment of effector cells
  • weakness, fatigue, joint pain
  • proteases and collagenases produced in joint cause damage to cartilage and erosion of supporting structures
30
Q

MS

A

t cell mediated

  • chronic organ specific disease
  • 1/700, 60% women
  • inflammation of brain (trigger?) leads to permeability of blood brain barrier
  • myelin sheath cover cells of spinal cord and brain destroyed due to TH1 CD4 cells which secrete IFN gamma and activate macrophages, also mast cell and complement activation
  • autoantibodies to myelin basic protein, proteolipid protein, MOG
  • symptoms may disappear and recur over time and include weakness, tremors, paralysis of one or more extremities, numbness, decreased memory and attention span
31
Q

treatments for AI

A
  • physical removal of the antigen, antibody, or immune complexes- splenectomy
  • IVIG
  • anti IF drugs
  • depletion of immune cells
  • blocking interaction/activation of immune cells (antiTNF, TNF antagonist, soluble CTLA4)
  • replacement therapy- insulin for diabetes
  • hormones, diet exercise